These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7650334)

  • 41. A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B.
    Andreone P; Cursaro C; Gramenzi A; Zavagliz C; Rezakovic I; Altomare E; Severini R; Franzone JS; Albano O; Ideo G; Bernardi M; Gasbarrini G
    Hepatology; 1996 Oct; 24(4):774-7. PubMed ID: 8855175
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferon: a meta-analysis of published studies in pediatric chronic hepatitis B.
    Vajro P; Migliaro F; Fontanella A; Orso G
    Acta Gastroenterol Belg; 1998; 61(2):219-23. PubMed ID: 9658614
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of low-dose alpha interferon therapy in HBV-related chronic liver disease in Asian Indians: a randomized controlled trial.
    Sarin SK; Guptan RC; Thakur V; Malhotra S; Malhotra V; Banerjee K; Khandekar P
    J Hepatol; 1996 Apr; 24(4):391-6. PubMed ID: 8738724
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interferon-alpha treatment of children with chronic hepatitis D virus infection: the Greek experience.
    Dalekos GN; Galanakis E; Zervou E; Tzoufi M; Lapatsanis PD; Tsianos EV
    Hepatogastroenterology; 2000; 47(34):1072-6. PubMed ID: 11020882
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of chronic viral hepatitis B in children with moderate doses of alpha interferon].
    Cullu F; Tümay GT; Kutlu T; Erkan T; Ozbay G; Badur S
    Gastroenterol Clin Biol; 1995 Jan; 19(1):53-7. PubMed ID: 7720991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapy for chronic hepatitis B with lymphoblastoid interferon-alpha and levamisole.
    Fattovich G; Giustina G; Brollo L; Guido M; Pontisso P; Noventa F; Alberti A
    Hepatology; 1992 Nov; 16(5):1115-9. PubMed ID: 1427652
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
    Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
    Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis B genotypes and the response to interferon therapy.
    Kao JH; Wu NH; Chen PJ; Lai MY; Chen DS
    J Hepatol; 2000 Dec; 33(6):998-1002. PubMed ID: 11131465
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interferon alfa therapy for chronic hepatitis B in children: a multinational randomized controlled trial.
    Sokal EM; Conjeevaram HS; Roberts EA; Alvarez F; Bern EM; Goyens P; Rosenthal P; Lachaux A; Shelton M; Sarles J; Hoofnagle J
    Gastroenterology; 1998 May; 114(5):988-95. PubMed ID: 9558288
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Therapy of chronic viral hepatitis type B in children after previous ineffective interferon-alpha treatment].
    Liberek A; Szaflarska-Popławska A; Łuczak G; Góra-Gebka M; Jankowska A; Łoś-Rycharskda E; Szlagatys-Sidorkiewicz A; Sikorska-Wiśniewska G; Bako W; Zagierski M; Czerwionka-Szaflarska M; Korzon M
    Med Wieku Rozwoj; 2007; 11(4):373-9. PubMed ID: 18605188
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of interferon in the treatment of chronic viral hepatitis.
    Gibas AL
    Gastroenterologist; 1993 Jun; 1(2):129-42. PubMed ID: 8049886
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study.
    Utili R; Sagnelli E; Gaeta GB; Galanti B; Nardiello S; Felaco FM; Pasquale G; Marrone A; Aprea L; Pizzella T
    J Hepatol; 1994 Feb; 20(2):163-7. PubMed ID: 8006395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiviral regimen complexity index as an independent predictor of sustained virologic response in patients with chronic hepatitis C.
    Galán RJ; Cidoncha EC; Martin MF; Rodriguez CC; Almeida CV; Verdugo RM
    J Manag Care Pharm; 2013; 19(6):448-53. PubMed ID: 23806058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B.
    Barbera C; Bortolotti F; Crivellaro C; Coscia A; Zancan L; Cadrobbi P; Nebbia G; Pillan MN; Lepore L; Parrella T
    Hepatology; 1994 Aug; 20(2):287-90. PubMed ID: 8045488
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute exacerbation during interferon alfa treatment of chronic hepatitis B: frequency and relation to serum beta-2 microglobulin levels.
    Akdogan M; Senturk H; Mert A; Tabak F; Ozbay G
    J Gastroenterol; 2003; 38(5):465-70. PubMed ID: 12768389
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT.
    Brouwer JT; Hansen BE; Niesters HG; Schalm SW
    J Hepatol; 1999 Feb; 30(2):192-8. PubMed ID: 10068095
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial.
    Schalm SW; Heathcote J; Cianciara J; Farrell G; Sherman M; Willems B; Dhillon A; Moorat A; Barber J; Gray DF
    Gut; 2000 Apr; 46(4):562-8. PubMed ID: 10716688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Low-levels of HBsAg quantification at 48-week in HBeAg-negative chronic hepatitis B patients are the advantageous population for HBsAg clearance].
    Yan YJ; Wang XX; Cao ZH; Lu JF; Jin Y; He ZM; Geng N; Ren S; Ma LN; Chen XY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):813-818. PubMed ID: 30616314
    [No Abstract]   [Full Text] [Related]  

  • 60. Antiviral effect of prolonged intermittent lymphoblastoid alpha interferon treatment in chronic hepatitis B.
    Janssen HL; Berk L; Schalm SW; Heijtink RA; Hess G; Rossol S; Meyer zum Buschenfelde KH; Chamuleau RA; Jansen PL; Reesink HW
    Gut; 1992 Aug; 33(8):1094-8. PubMed ID: 1398234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.